PAVmed Historical Cash Flow
| PAVM Stock | USD 1.11 0.14 14.43% |
Analysis of PAVmed cash flow over time is an excellent tool to project PAVmed Inc future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 20.4 M or Depreciation of 3.1 M as it is a great indicator of PAVmed ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining PAVmed Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether PAVmed Inc is a good buy for the upcoming year.
PAVmed |
About PAVmed Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in PAVmed balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which PAVmed's non-liquid assets can be easily converted into cash.
PAVmed Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Capital Expenditures
Capital Expenditures are funds used by PAVmed Inc to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of PAVmed operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from PAVmed's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into PAVmed Inc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. At this time, PAVmed's Begin Period Cash Flow is very stable compared to the past year. As of the 3rd of December 2024, Investments is likely to grow to about 675.1 K, though Change In Cash is likely to grow to (19.1 M).
PAVmed cash flow statement Correlations
Click cells to compare fundamentals
PAVmed Account Relationship Matchups
High Positive Relationship
High Negative Relationship
PAVmed cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 67.4B | 357K | 436M | (366K) | 259M | 246.1M | |
| Change In Cash | (2.0M) | 11.0M | 60.0M | (37.5M) | (20.1M) | (19.1M) | |
| Net Borrowings | 6.2M | 16.7M | (14.8M) | 35.2M | 40.5M | 42.5M | |
| Stock Based Compensation | 1.6M | 2.0M | 15.0M | 19.5M | 11.1M | 5.8M | |
| Free Cash Flow | (13.4M) | (22.0M) | (42.1M) | (72.5M) | (52.3M) | (49.7M) | |
| Change In Working Capital | (63.9K) | 83K | (1.6M) | (716K) | 1.6M | 1.7M | |
| Total Cashflows From Investing Activities | (27.2K) | (55K) | (3.7M) | (4.7M) | (4.3M) | (4.1M) | |
| Other Cashflows From Financing Activities | 6.2M | 17.6M | 2.3M | 1.5M | 19.4M | 20.4M | |
| Depreciation | 14.2K | 23K | 226K | 2.5M | 2.9M | 3.1M | |
| Other Non Cash Items | 558.6K | 5.3M | (1.5M) | 11.0M | (3.5M) | (3.3M) | |
| Capital Expenditures | 27.2K | 55K | 1.5M | 1.5M | 242K | 377.4K | |
| Total Cash From Operating Activities | (13.4M) | (21.9M) | (40.6M) | (71.0M) | (52.0M) | (49.4M) | |
| Change To Operating Activities | (677.2K) | (418K) | (1.5M) | (157K) | (141.3K) | (148.4K) | |
| Net Income | (17.3M) | (35.9M) | (56.1M) | (103.2M) | (64.2M) | (61.0M) | |
| Total Cash From Financing Activities | 11.4M | 33.0M | 104.3M | 38.2M | 31.2M | 27.3M | |
| End Period Cash Flow | 6.2M | 17.3M | 77.3M | 39.7M | 19.6M | 19.0M | |
| Change To Netincome | 1.6M | 12.3M | 15.1M | 16.3M | 18.7M | 19.6M | |
| Change To Liabilities | 669.3K | 501K | 2.1M | (742K) | (853.3K) | (810.6K) | |
| Begin Period Cash Flow | 8.2M | 6.2M | 17.3M | 77.3M | 39.7M | 41.7M | |
| Dividends Paid | 67.4B | 357K | 436M | 35.2M | 12.5B | 9.8B | |
| Investments | (27.2K) | (55K) | (3.7M) | (4.7M) | 643K | 675.2K | |
| Cash And Cash Equivalents Changes | 6.7M | (2.0M) | 11.0M | 60.0M | 69.0M | 72.5M | |
| Cash Flows Other Operating | (13.0M) | 1.7M | 10.5M | (1.7M) | (2.0M) | (1.9M) | |
| Issuance Of Capital Stock | 5.5M | 16.0M | 117.0M | 1.9M | 15.6M | 29.4M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.14) | Revenue Per Share 0.459 | Quarterly Revenue Growth 4.898 | Return On Assets (0.80) | Return On Equity (13.58) |
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.